6.
Lu J, Wu T, Zhang B, Liu S, Song W, Qiao J
. Types of nuclear localization signals and mechanisms of protein import into the nucleus. Cell Commun Signal. 2021; 19(1):60.
PMC: 8140498.
DOI: 10.1186/s12964-021-00741-y.
View
7.
Chen Y, Toth R, Chocarro S, Weichenhan D, Hey J, Lutsik P
. Club cells employ regeneration mechanisms during lung tumorigenesis. Nat Commun. 2022; 13(1):4557.
PMC: 9356049.
DOI: 10.1038/s41467-022-32052-2.
View
8.
Khalil A, Wurthwein G, Golitsch J, Hempel G, Fobker M, Gerss J
. Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia. Haematologica. 2020; 107(1):49-57.
PMC: 8719085.
DOI: 10.3324/haematol.2020.258525.
View
9.
Rawlins E, Okubo T, Xue Y, Brass D, Auten R, Hasegawa H
. The role of Scgb1a1+ Clara cells in the long-term maintenance and repair of lung airway, but not alveolar, epithelium. Cell Stem Cell. 2009; 4(6):525-34.
PMC: 2730729.
DOI: 10.1016/j.stem.2009.04.002.
View
10.
Stone Jr C, Liu Y, Relling M, Krantz M, Pratt A, Abreo A
. Immediate Hypersensitivity to Polyethylene Glycols and Polysorbates: More Common Than We Have Recognized. J Allergy Clin Immunol Pract. 2018; 7(5):1533-1540.e8.
PMC: 6706272.
DOI: 10.1016/j.jaip.2018.12.003.
View
11.
Lim K, Maruyama R, Yokota T
. Eteplirsen in the treatment of Duchenne muscular dystrophy. Drug Des Devel Ther. 2017; 11:533-545.
PMC: 5338848.
DOI: 10.2147/DDDT.S97635.
View
12.
Evans B, King A, Katsifis A, Matesic L, Jamie J
. Methods to Enhance the Metabolic Stability of Peptide-Based PET Radiopharmaceuticals. Molecules. 2020; 25(10).
PMC: 7287708.
DOI: 10.3390/molecules25102314.
View
13.
Laucho-Contreras M, Polverino F, Gupta K, Taylor K, Kelly E, Pinto-Plata V
. Protective role for club cell secretory protein-16 (CC16) in the development of COPD. Eur Respir J. 2015; 45(6):1544-56.
PMC: 4451404.
DOI: 10.1183/09031936.00134214.
View
14.
Miyatake S, Mizobe Y, Takizawa H, Hara Y, Yokota T, Takeda S
. Exon Skipping Therapy Using Phosphorodiamidate Morpholino Oligomers in the mdx52 Mouse Model of Duchenne Muscular Dystrophy. Methods Mol Biol. 2017; 1687:123-141.
DOI: 10.1007/978-1-4939-7374-3_9.
View
15.
Sazani P, Gemignani F, Kang S, Maier M, Manoharan M, Persmark M
. Systemically delivered antisense oligomers upregulate gene expression in mouse tissues. Nat Biotechnol. 2002; 20(12):1228-33.
DOI: 10.1038/nbt759.
View
16.
Go Y, Jones D
. Redox compartmentalization in eukaryotic cells. Biochim Biophys Acta. 2008; 1780(11):1273-90.
PMC: 2601570.
DOI: 10.1016/j.bbagen.2008.01.011.
View
17.
Nawroth J, van der Does A, Ryan Firth A, Kanso E
. Multiscale mechanics of mucociliary clearance in the lung. Philos Trans R Soc Lond B Biol Sci. 2019; 375(1792):20190160.
PMC: 7017338.
DOI: 10.1098/rstb.2019.0160.
View
18.
Dang Y, van Heusden C, Nickerson V, Chung F, Wang Y, Quinney N
. Enhanced delivery of peptide-morpholino oligonucleotides with a small molecule to correct splicing defects in the lung. Nucleic Acids Res. 2021; 49(11):6100-6113.
PMC: 8216463.
DOI: 10.1093/nar/gkab488.
View
19.
Moulton H, Moulton J
. Morpholinos and their peptide conjugates: therapeutic promise and challenge for Duchenne muscular dystrophy. Biochim Biophys Acta. 2010; 1798(12):2296-303.
DOI: 10.1016/j.bbamem.2010.02.012.
View
20.
Cirak S, Arechavala-Gomeza V, Guglieri M, Feng L, Torelli S, Anthony K
. Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study. Lancet. 2011; 378(9791):595-605.
PMC: 3156980.
DOI: 10.1016/S0140-6736(11)60756-3.
View